Hypothalamic–pituitary–adrenal axis function in patients with chronic depression
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background. Hypothalamic–pituitary–adrenal (HPA) axis function in patients with chronic depression has previously been shown to be normal when measured using the dexamethasone suppression test (DST). We examined patients with chronic depression using the sensitive dexamethasone/corticotropin releasing hormone (dex/CRH) test and the dexamethasone suppression test (DST) to establish whether HPA axis abnormalities are present in this group. We also compared the sensitivity of the two tests and compared the results with previous studies in depression that have not specifically selected chronic patients. Method. Twenty-nine patients with the chronic subtype of major depressive disorder and 28 matched controls underwent examination of HPA axis function. Results. Neither the cortisol response to the DST or the dex/CRH test differed significantly between the patient and control groups. There was a trend in favour of more patients than controls having an abnormal response to the dex/CRH test (P = 0.052). Neither the patients with an abnormally enhanced response, nor the magnitude of response could be predicted by any illness or demographic variable. Conclusion. The HPA axis is not overtly abnormal in chronic depression. This contrasts with previous findings in acute depression and bipolar disorder and may suggest that the HPA axis abnormalities present in acute depression resolve, but are not accompanied by symptom resolution. Alternatively, a subgroup of depressives with less HPA dysfunction may progress to chronicity. This has implications for treatment and prognosis. The dex/CRH is a more sensitive test of HPA axis function than the DST in patients with chronic depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The findings for studies measuring diurnal cortisol and CAR in MDD have been inconsistent.”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [25]
In the citing paper
“Patients with DSM-IV depressive disorder had higher concentrations of cortisol and a steeper slope than the controls [25].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [25]
In the citing paper
“There are those that have demonstrated significant differences, demonstrating those with MDD to have higher measures than their non-depressed counterparts, like the ones mentioned above.”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [25]
In the citing paper
“On the other hand, there are also those that have not found a significantly hyperactive HPA axis in depression [25].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [25]
In the citing paper
“patients with chronic depression do not differ from healthy control subjects on the DEX suppression test (Watson et al. 2002)”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Watson et al. 2002
Citations
Cites
Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997) · American Psychiatric Press eBooks · Cited by 3,101
Smithson, M. (2000) · SAGE Publications Ltd eBooks · doi:10.4135/9781446218525 · Cited by 1,871
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 1×
“For instance, it is noteworthy that cognitive behavioural therapies have been shown to be efficacious in the treatment of chronic treatment resistant depression (Fava et al. 1997; Keller et al. 2000).”
BackgroundKeller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Hays, R. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130011002 · Cited by 841
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Shah, P. J., Ebmeier, K. P., Glabus, M. F., & Goodwin, G. M. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.6.527 · Cited by 395
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354 · cited 3×
“Patients in previous studies have been drug free (Heuser et al. 1994), on a range of psychotropic drugs (Zobel et al. 2001) or medication has not been reported (Rybakowski & Twardowska, 1999).”
BackgroundResultRisk for Bipolar Illness in Patients Initially Hospitalized for Unipolar Depression
Goldberg, J. F., Harrow, M., & Whiteside, J. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1265 · Cited by 319
Cited by
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“Moreover, the HPA-axis is not overtly abnormal in chronic depression, not even when tested with a sensitive dexamethasone/CRH test (Watson et al., 2002).”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
“In depressed patients this is reflected by basal hypercortisolemia and cortisol escape from dexamethasone suppression (Carroll, 1984), as well as an increased ACTH and cortisol release in the combined dexamethasone suppression/CRH-stimulation test (Dex—CRH test) (Heuser et al., 1994; von Bardeleben and Holsboer, 1991;…”
BackgroundMajor depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792
The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
“The elevated levels of IL-1 beta appear to occur when an individual is unable to cope and succumbs to a stressful event, thus showing sickness behavior symptoms [25].”
BackgroundInfluentialFrodl, T., & O'Keane, V. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.012 · Cited by 555
“even exaggerated DEX/CRH responses (O'Keane et al., 2005; Watson et al., 2002).”
BackgroundShea, A., Walsh, C., MacMillan, H., & Steiner, M. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.07.001 · Cited by 378
“Both chronicity and the number of previous episodes of depression have been associated with variability in cortisol levels, which may help to explain heterogeneity of reports (Watson et al., 2002; Rybakowski and Twardowska, 1999).”
BackgroundIsing, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341
Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression
van Rossum, E. F. C., Binder, E. B., Majer, M., Koper, J. W., Ising, M., Modell, S., Salyakina, D., Lamberts, S. W. J., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.007 · Cited by 324
Knorr, U., Vinberg, M., Kessing, L. V., & Wetterslev, J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.04.001 · Cited by 317
“…controls (den Hartog et al., 2003), colleges (Galard et al., 2002; Juruena et al., 2006) and other community sources (Colomina et al., 1997; Young et al., 2002; Watson et al., 2002; Strickland et al., 2002; Porter et al., 2003; O’Brien et al., 2004; Bhagwagar et al., 2005; Vreeburg et al., 2009).”
BackgroundMethodResultInfluentialInsomnia causes, consequences, and therapeutics: An overview
Drake, C. L., Roehrs, T., & Roth, T. (2003) · Depression and Anxiety · doi:10.1002/da.10151 · Cited by 308
The combined dexamethasone/CRH test as a potential surrogate marker in depression
Ising, M., Künzel, H. E., Binder, E. B., Nickel, T., Modell, S., & Holsboer, F. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.014 · Cited by 271
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265
“Recent work has also shown how differences in dexamethasone metabolism, rather than MDD symptoms, can better explain variance in cortisol levels (109), though studies have attempted to control for this by directly sampling serum dexamethasone (14).”
BackgroundKunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Stetler, C., & Miller, G. E. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.4.697 · Cited by 200
Pompili, M., Serafini, G., Innamorati, M., Möller-Leimkühler, A. M., Giupponi, G., Girardi, P., Tatarelli, R., & Lester, D. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0108-z · Cited by 161
Haapakoski, R., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.012 · Cited by 157
Hypothalamic‐Pituitary‐Adrenocortical Axis: Neuropsychiatric Aspects
Jacobson, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130036 · Cited by 144
Levels and variability of daily life cortisol secretion in major depression
Peeters, F. P. M. L., Nicolson, N. A., & Berkhof, J. H. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2003.12.010 · Cited by 158
Brain-immune interactions and disease susceptibility
Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 151
O’Keane, V., Frodl, T., & Dinan, T. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.009 · Cited by 140
Xia, X., Cheng, G., Pan, Y., Xia, Z. H., & Kong, L. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.09.042 · Cited by 135
Boal, A. H., Smith, D. J., McCallum, L., Muir, S., Touyz, R. M., Dominiczak, A. F., & Padmanabhan, S. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08188 · Cited by 125
Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal
Ibargüen-Vargas, Y., Surget, A., Touma, C., Palme, R., & Belzung, C. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.010 · Cited by 137
Biochemical markers subtyping major depressive disorder
Kunugi, H., Hori, H., & Ogawa, S. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12299 · Cited by 114
Animal models of depression: navigating through the clinical fog
Matthews, K., Christmas, D. M. B., Swan, J., & Sorrell, E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.005 · Cited by 126
Medial temporal lobe abnormalities in pediatric unipolar depression
Caetano, S. C., Fonseca, M., Hatch, J. P., Olvera, R. L., Nicoletti, M., Hunter, K., Lafer, B., Pliszka, S. R., & Soares, J. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.014 · Cited by 119
Open questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 109
Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.
Weinstein, A. A., Deuster, P. A., Francis, J. L., Bonsall, R. W., Tracy, R. P., & Kop, W. J. (2010) · Biological Psychology · doi:10.1016/j.biopsycho.2010.01.016 · Cited by 113
Juruena, M. F., Pariante, C. M., Papadopoulos, A. S., Poon, L., Lightman, S., & Cleare, A. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.050278 · Cited by 114
O’Keane, V., Dinan, T. G., Scott, L., & Corcoran, C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.049 · Cited by 111
Cognitive-behavioural theories of helplessness/hopelessness: Valid models of depression?
Bussfeld, P., Hegerl, U., M�ller, H.-J., & Henkel, V. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0389-y · Cited by 145
Sulforaphane produces antidepressant- and anxiolytic-like effects in adult mice
Wu, S., Gao, Q., Zhao, P., Gao, Y., Xi, Y., Wang, X., Liang, Y., Shi, H., & Ma, Y. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.030 · Cited by 97
Pan, Y., Kong, L., Li, Y., Xia, X. H., Kung, H., & Jiang, F.-X. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.009 · Cited by 96
Jutkiewicz, E. M., Wood, S. K., Houshyar, H., Hsin, L., Rice, K. C., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2164-z · Cited by 89
Salivary cortisol and suicidal behavior—A follow-up study
Lindqvist, D., Isaksson, A., Lil-Träskman-Bendz, & Brundin, L. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.012 · Cited by 100
Rothe, N., Steffen, J., Penz, M. S., Kirschbaum, C., & Walther, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.024 · Cited by 96
Sex differences in hormonal responses to a social stressor in chronic major depression
Chopra, K. K., Ravindran, A., Kennedy, S. H., Mackenzie, B., Matthews, S., Anisman, H., Bagby, R. M., Farvolden, P., & Levitan, R. D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.014 · Cited by 86
“All rights reserved. doi:10.1016/j.psyneuen.2009.03.014 1 Similar to Watson et al. (2002), we concluded a priori that a drug free study would be desirable but impractical in this population.”
BackgroundResultInfluentialThe dex/CRH test—Is it better than the DST?
Watson, S., Gallagher, P., Smith, M. S., Ferrier, I. N., & Young, A. H. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.03.001 · Cited by 100
Self-citationVon Werne Baes, C., de Carvalho Tofoli, S. M., Martins, C. M. S., & Juruena, M. F. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00610.x · Cited by 80
The DEX/CRH test for major depression: A potentially useful diagnostic test
Mokhtari, M., Arfken, C., & Boutros, N. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.032 · Cited by 79
“001 HC1⁄430 Watson et al. (2006) Mood disorders1⁄482 Significant for both patient groups vs.”
BackgroundResultInfluentialJaako, K., Zharkovsky, T., Pedersen, M. V., & Zharkovsky, A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9090-4 · Cited by 88
Galigniana, N. M., Ballmer, L. T., Toneatto, J., Erlejman, A. G., Lagadari, M., & Galigniana, M. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07775.x · Cited by 77
The Role of Saliva Cortisol Measurement in Health and Disease
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816080534211120101 · Cited by 73
Prevalence of Insomnia and Impact on Quality of Life among Community Elderly Subjects with Tinnitus
Lasisi, A. O., & Gureje, O. (2011) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348941112000402 · Cited by 74
Wei, J., Sun, G., Zhao, L., Yang, X., Liu, X., Lin, D., Li, T., & Ma, X. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.023 · Cited by 84
Wahlberg, K., Ghatan, P. H., Modell, S., Nygren, Å., Ingvar, M., Åsberg, M., & Heilig, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.035 · Cited by 70
Are there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 74
The role of mineralocorticoid receptor function in treatment-resistant depression
Juruena, M. F., Pariante, C. M., Papadopoulos, A. S., Poon, L., Lightman, S., & Cleare, A. J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113499205 · Cited by 70
Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls
Carpenter, L. L., Ross, N. S., Tyrka, A. R., Anderson, G. M., Kelly, M., & Price, L. H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.009 · Cited by 70
Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Mechanisms of brain glucocorticoid resistance in stress-induced psychopathologies
Merkulov, V. M., Merkulova, T. I., & Bondar, N. P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030142 · Cited by 65
Stone, E. A., Lin, Y., Rosengarten, H., Kramer, H. K., & Quartermain, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300222 · Cited by 69
Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety
Veen, G., van Vliet, I. M., DeRijk, R. H., Giltay, E. J., van Pelt, J., & Zitman, F. G. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2009.07.013 · Cited by 58
“This is in linewithprevious studies on anxiety disorders, characterized by arousal symptomsshowing that basal cortisolwasunalteredas compared to controls (Heuser et al.,1994; Schreiber et al.,1996;Watson et al., 2002; Strohle and Holsboer, 2003; Stewart et al., 2005; Erhardt et al., 2006; Abelson et al., 2007; van Vee…”
BackgroundMolecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review
de Oliveira, M. R., Chenet, A. L., Duarte, A. R., Scaini, G., & Quevedo, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0680-6 · Cited by 57
McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47
Self-citationCortisol and depression in pre-diagnosed and early stage Huntington's disease
Shirbin, C. A., Chua, P. M.-L., Churchyard, A., Lowndes, G., Hannan, A. J., Pang, T. Y., Chiu, E. Y.-K., & Stout, J. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.020 · Cited by 53
Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments
Porter, R. J., & Gallagher, P. (2006) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2006.00152.x · Cited by 45
Self-citationPloski, J. E., & Vaidya, V. A. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.009 · Cited by 51
Horstmann, S., Dose, T., Lucae, S., Kloiber, S., Menke, A., Hennings, J., Spieler, D., Uhr, M., Holsboer, F., & Ising, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.004 · Cited by 44
“…depression (von Bardeleben and Holsboer, 1989; Heuser et al., 1994a), from bipolar disorder (Rybakowski and Twardowska, 1999), chronic depression (Watson et al., 2002), dysthymic disorder (Oshima et al., 2000), and panic disorder (Erhardt et al., 2006), when compared with healthy controls,…”
BackgroundSchmelting, B., Corbach‐Söhle, S., Kohlhause, S., Schlumbohm, C., Flügge, G., & Fuchs, E. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.010 · Cited by 45
Martin, D. J., Haq, Z. U., Nicholl, B. I., Cullen, B., Evans, J. J., Gill, J. M. R., Roberts, B. A., Gallacher, J., Mackay, D., McIntosh, A. M., et al. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.157784 · Cited by 46
Watson, S., Owen, B. M., Gallagher, P., Hearn, A. J., Young, A. H., & Ferrier, I. N. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a939 · Cited by 41
Self-citationLindqvist, D., Träskman-Bendz, L., & Vang, F. (2008) · Archives of Suicide Research · doi:10.1080/13811110802100775 · Cited by 36
Antiglucocoticoid Treatments for Depression
Young, A. H. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01813.x · Cited by 36
Self-citationVirtual Reality Therapy for Depression and Mood in Long-Term Care Facilities
Zhai, K., Dilawar, A., Yousef, M. S., Holroyd, S., El-Hammali, H., & Abdelmonem, M. (2021) · Geriatrics · doi:10.3390/geriatrics6020058 · Cited by 40
Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders
Watson, S., Gallagher, P., Ferrier, I. N., & Young, A. H. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.08.001 · Cited by 38
Self-citationCognitive correlates of hypothalamic–pituitary–adrenal axis in major depression
Schlosser, N., Wolf, O. T., & Wingenfeld, K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.79 · Cited by 33
Paslakis, G., Krumm, B., Gilles, M., Schweiger, U., Heuser, I., Richter, I., & Deuschle, M. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.002 · Cited by 33
Fedotova, J., Dudnichenko, T., Kružliak, P., & Puchavskaya, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.107 · Cited by 33
Ehnvall, A., Sjögren, M. J. C., Zachrisson, O., & �gren, H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0512-3 · Cited by 32
Green, C., Stolicyn, A., Harris, M. A., Shen, X., Romaniuk, L., Barbu, M. C., Hawkins, E. L., Wardlaw, J. M., Steele, J. D., Waiter, G. D., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01644-9 · Cited by 28
Kumar, A. M., Solano, M. P., Fernandez, J. B., & Kumar, M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087381 · Cited by 34
Choi, W., Kang, H., Kim, J., Kim, H. K., Kang, H., Lee, J., Kim, S., Stewart, R. J., & Kim, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.054 · Cited by 23
Hori, H., Teraishi, T., Sasayama, D., Hattori, K., Hashikura, M., Higuchi, T., & Kunugi, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.022 · Cited by 23
Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients
Watson, S., Gallagher, P., Smith, M. S., Young, A. H., & Ferrier, I. N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.010 · Cited by 23
Self-citationThe influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression
Veen, G., DeRijk, R. H., Giltay, E. J., van Vliet, I. M., PELT, J. V., & Zitman, F. G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.007 · Cited by 22
Association between cortisol levels and pain threshold in systemic sclerosis and major depression
Bagnato, G., Cordova, F., Sciortino, D., Miceli, G., Bruno, A., Ferrera, A., Sangari, D., Coppolino, G., Muscatello, M. R. A., Pandolfo, G., et al. (2017) · Rheumatology International · doi:10.1007/s00296-017-3866-3 · Cited by 20
Feng, S., Liu, J., Cheng, B., Deng, A., & Zhang, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5936 · Cited by 18
Isogawa, K., Nagayama, H., Tsutsumi, T., Kiyota, A., Akiyoshi, J., & Hieda, K. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.11.003 · Cited by 17
Paslakis, G., Heuser, I., Schweiger, U., & Deuschle, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.010 · Cited by 21
Can Molecular Biology Propose Reliable Biomarkers for Diagnosing Major Depression?
Ivanets, N. N., Svistunov, A. А., Chubarev, V. N., Kinkulkina, M. A., Tikhonova, Y. G., Syzrantsev, N. S., Sologova, S. S., Ignatyeva, N. V., Mutig, K., & Tarasov, V. V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201124110437 · Cited by 18
Clark, J. E., Osborne, J. W., Gallagher, P., & Watson, S. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2528 · Cited by 16
Self-citationThe Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
Markov, D. D., Dolotov, O. V., & Grivennikov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076664 · Cited by 14
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
von Zimmermann, C., Böhm, L., Richter-Schmidinger, T., Kornhuber, J., Lenz, B., & Mühle, C. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02288-7 · Cited by 13
Ferrier, I. N., Anderson, I. M., Barnes, J. A., Gallagher, P., Grunze, H., Haddad, P. M., House, A. O., Hughes, T. E., Lloyd, A. J., Mamasoula, C., et al. (2015) · Efficacy and Mechanism Evaluation · doi:10.3310/eme02040 · Cited by 14
Self-citationSoultanov, V., Fedotova, J., Nikitina, T. V., Roschin, V., Ordyan, N., & Hriţcu, L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9848-8 · Cited by 14
The Burden of Preoperative Stress: Biological Mechanisms and Postoperative Outcomes
Syed, A., Menezes, T., Bisenius, A., Sič, A., & Knežević, N. N. (2026) · Brain Sciences · doi:10.3390/brainsci16020219 · Cited by 15
Li, X., Wang, H., Chen, Q., Li, Z., Liu, C., Yin, S., & You, Z. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12466 · Cited by 11
(2013) · PubMed
Jones, B. D. M., Chopra, K. K., Grummitt, J., Ravindran, A. V., Matthews, S. G., & Levitan, R. D. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.06.006 · Cited by 11
Hypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance
Yunilaynen, O. A., Starostina, E. G., & Oleichik, I. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-1-73-90 · Cited by 10
Carpenter, L. L., Tyrka, A. R., Lee, J. K., Tracy, A. P., Wilkinson, C. W., & Price, L. H. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2336-y · Cited by 7
Douglas, K. M., & Porter, R. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02364.x · Cited by 9
Saliva cortisol and male depressive syndrome in a community study. The Sudurnesjamenn study
Sigurðsson, B., Palsson, S. P., Jóhannsson, M., Ólafsdóttir, M., & Aevarsson, Ó. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.704069 · Cited by 7
The effect of treatment with ketoconazole on central CRH systems of depressed patients
Paslakis, G., Lecei, O., Stalla, G. K., Landgraf, R., Uhr, M., Hamann, B., Luppa, P. B., Gilles, M., Heuser, I., & Deuschle, M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1167 · Cited by 5
Fedotova, J., & Hriţcu, L. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.09.006 · Cited by 5
RetractedFedotova, J., Акулова, В. К., Пивина, С. Г., Dragašek, J., Čaprnda, M., & Kružliak, P. (2017) · PubMed Central · Cited by 7
Tsuru, J., Akiyoshi, J., Tanaka, Y., Matsushita, H., Hanada, H., Kodama, K., Hikichi, T., Ohgami, H., Tsutsumi, T., Isogawa, K., et al. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.02.001 · Cited by 5
The Hypothalamic–Pituitary–Adrenal Axis in Bipolar Disorder
Bond, D. J., & Young, A. H. (2007) · Medical psychiatry · doi:10.3109/9781420021158.008 · Cited by 3
Self-citation
Metadata
- Authors
- WATSON, S., GALLAGHER, P., DEL-ESTAL, D., HEARN, A., FERRIER, I. N., & YOUNG, A. H.
- Affiliations
- Royal Victoria Infirmary (GB)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2002-08
- Volume
- 32
- Issue
- 6
- Pages
- 1021-1028
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2141456647
- Semantic Scholar
- ce025f580e24d208b802ed5068dc90d24f144205
- Cited by
- 130
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 5 · 2021: 5 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 3 · 2013: 6 · 2012: 9
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Psychological Medicine (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- hypothalamic-pituitary-adrenal axis, chronic depression, major depressive disorder, dexamethasone suppression test, dexamethasone/corticotropin-releasing hormone test, cortisol response, HPA axis dysregulation, test sensitivity
- MeSH terms
- Adult, Chronic Disease, Corticotropin-Releasing Hormone, Major Depressive Disorder, Dexamethasone, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Saliva, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.